Corteva, Inc. $CTVA Shares Acquired by Russell Investments Group Ltd.

Russell Investments Group Ltd. lifted its holdings in Corteva, Inc. (NYSE:CTVA) by 14.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 736,515 shares of the company’s stock after buying an additional 92,624 shares during the period. Russell Investments Group Ltd. owned approximately 0.11% of Corteva worth $49,811,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Activest Wealth Management grew its stake in Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after acquiring an additional 200 shares in the last quarter. True Wealth Design LLC lifted its stake in Corteva by 209.5% in the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after purchasing an additional 264 shares in the last quarter. Total Investment Management Inc. acquired a new position in shares of Corteva during the 2nd quarter worth approximately $27,000. Twin Peaks Wealth Advisors LLC acquired a new position in shares of Corteva during the 2nd quarter worth approximately $29,000. Finally, Redmont Wealth Advisors LLC purchased a new stake in shares of Corteva in the third quarter valued at approximately $29,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Stock Performance

NYSE:CTVA opened at $78.65 on Thursday. Corteva, Inc. has a fifty-two week low of $53.40 and a fifty-two week high of $80.90. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The company has a 50 day moving average price of $73.63 and a 200 day moving average price of $69.13. The stock has a market capitalization of $52.89 billion, a P/E ratio of 49.78, a PEG ratio of 2.61 and a beta of 0.72.

Corteva (NYSE:CTVA) last announced its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. During the same quarter in the previous year, the company earned $0.32 earnings per share. The firm’s quarterly revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts forecast that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Monday, March 2nd. Corteva’s payout ratio is currently 45.57%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on CTVA shares. Deutsche Bank Aktiengesellschaft increased their price target on Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a report on Thursday, February 5th. CICC Research upped their target price on Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a report on Wednesday, February 11th. Jefferies Financial Group raised their target price on Corteva from $85.00 to $95.00 and gave the stock a “buy” rating in a research note on Monday, March 2nd. Oppenheimer set a $86.00 price target on Corteva in a report on Thursday, February 5th. Finally, Argus raised shares of Corteva to a “strong-buy” rating in a research report on Friday, January 16th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $82.90.

Insider Transactions at Corteva

In related news, insider Brian Titus sold 8,311 shares of the stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This represents a 50.67% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.14% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.